{
  "created_at": "2020-09-18T04:50:43.000Z",
  "updated_at": "2021-01-06T08:25:09.400Z",
  "id": "725d5175-9c0c-42f2-a6d9-32e549366a1a",
  "labels": "current-affairs,2020-09-19",
  "question": "Which body has permitted Serum Institute of India to resume COVID-19 vaccine trials?",
  "option1": "Drugs Controller General of India",
  "option2": "Ministry of Health",
  "option3": "National Pharma Pricing Authority",
  "option4": "Drugs Bureau of India",
  "option5": "",
  "answer": "Drugs Controller General of India",
  "explanation": "The Drugs Controller General of India (DCGI) has permitted SII - Serum Institute of India to resume clinical trials of COVID vaccine, which was paused last week as per an order by DCGI.<br />The SII is conducting trials of the vaccine being developed by Oxford Universityâ€™s Jenner Institute and Astra Zeneca. DCGI has advised SII to take additional care during the trial and to submit the details of medication to ensure that it in accordance with the protocol for the management of adverse events."
}